Pancreatic juice was collected in vivo from control and reserpine-treted rats after stimulation with pilocarpine (0.2 mg/100 g body weight), dopamine (6-7 mg/100 g body weight), caerulein (90-100 pmole total dose) or with a combination of caerulein and secretin (6 u/100 g body weight) and the volume, amylase, bicarbonate and chloride outputs were compared. The results indicate that the secretory response to the three secretagogues was significantly reduced in the drug treated animals. Thus, the volumes of pancreatic juice were 57.0,60.5, and 15.7% of those obtained in control rats after stimulation with, respectively, pilocarpine, dopamine, and caerulein. Amylase output was 63.8, 67.1, and 21.0% and bicarbonate output was 29.9,44.8, and 6.2% of those observed in untreated rats after the same stimulants. Fluid secretion increased in the treated animals to 71.3% of that of controls when both caerulein and secretin were administered together and amylase output became greater than in control rats (151%). However.
Summary
Pancreatic juice was collected in vivo from control and reserpine-treted rats after stimulation with pilocarpine (0.2 mg/100 g body weight), dopamine (6-7 mg/100 g body weight), caerulein (90-100 pmole total dose) or with a combination of caerulein and secretin (6 u/100 g body weight) and the volume, amylase, bicarbonate and chloride outputs were compared. The results indicate that the secretory response to the three secretagogues was significantly reduced in the drug treated animals. Thus, the volumes of pancreatic juice were 57.0,60.5, and 15.7% of those obtained in control rats after stimulation with, respectively, pilocarpine, dopamine, and caerulein. Amylase output was 63.8, 67.1, and 21.0% and bicarbonate output was 29.9,44.8, and 6.2% of those observed in untreated rats after the same stimulants. Fluid secretion increased in the treated animals to 71.3% of that of controls when both caerulein and secretin were administered together and amylase output became greater than in control rats (151%). However.
involving two distinct portions of the glandular epithelium. Thus, secretion of enzymes from acinar cells is regulated by both the cholinergic innervation and by cholecystokin~n-pancre&ymin (3, 7. 8. 11. 13) . Secretion of the water/electrolvte fraction of pan-. .
. , creatic juice is thought to take place in centroicinar and duct 'cells under the influence of secretin (3, 7, 8, 1 I, 13) . The results of the previous study on the pancreatic secretory response of reserpinetreated rats suggested, therefore, that the drug treatment affected the function of both acinar and duct cells and impaired their response to hormonal regulators.
In this investigation, a further analysis of the pancreatic secretory response in the reserpine-treated rat has been conducted by studying the volume of pancreatic juice, the excretion of bicarbonate and the excretion of amylase induced by neurohomoral mediators. In adition, the effects of the peptide caerulein have been investigated, by way of comparison with those of cholecystokinin and of the autonomic agents.
bicarbonate output was still 55.2% of that of controls with this combined stimulation. It is concluded that chronic reserpine ad-
MATERIALS A N D METHODS
ministration impairs exocrine pancreatic secretion and that this effect involves both the acinar and ductal portions of the gland.
rats of the 'prague Daw'e~ strain were used* The This impaiment involves the physiologic responses of these two treated group received seven (0.5 mg/kg) segments of the glandular epithelium to both neural and hormonal i~ as previously described (99 lo). The Ones as stimulants. These findings suggest that the exocrine pancreatic llntreated were housed in the same quarters with the disturbance in reserpine-treated rats may be similar to that ob-treated Ones and were for were served in cystic fibrosis (CF), and because the treated rat has been free access water and a standard pelleted diet but were proposed as a model for the human disease, they suggest the use of food, but not water, during the last 24 before of this model as a test system for the study of the pancreatic killing. On the 8th day, they were anesthetized with an ip injection secretory abnormality in CF. of sodium pentobarbital (6-8 mg/100 g body weight) and cannulae were inserted into the trachea and the jugular vein. The duodenal portion of the pancreas was exposed through a midline abdominal Speculation incision, the common bile duct was identified and 2-3 mm were Rats treated in a chronic fashion with reserpine secrete sjgoifi-carefully freed in its distal end in order to identify its entrance cantly smaller amounts of fluid, amylase, and bicarbonate in into the duodenum. A loose double ligature was passed around pancreatic juice than control animals, whether secretion is elicited the free portion of the duct and a third one was looped at the by hormonal or neural stimulants. The abnormality in exocrine distal end under 20 X manigfication with a Leitz stereo dissecting pancreatic function induced by the drug treatment involves, there-microscope and a polyethylene cannula (Clay Adams PE 10) was fore, the acinar and ductal segments of the gland and is similar to inserted for 1-2 mm into the duct lumen. Spontaneous flow 01 the alteration seen in patients with CF.
bile-stained fluid began immediately. The hepatic end of the duct was then tied and the fluid flow decreased. This resting flow was allowed to continue until the fluid appearing at the tip of the Rats treated in a chronic fashion with reserpine show marked cannula was clear. At this time, secretagogues were either injected secretory disturbances in several exocrine glands which resemble or infused through the catheter placed in the jugular vein. In the those observed in patients with CF (9, 10, 12, 14) . In the pancreas, second case, the stimulants were infused by using a constant the effect of the drug treatment is manifested by the secretion of infusion pump. Infusions were continued for approximatley 30 smaller volumes of pancreatic juice in response to cholecystokinin min, and pancreatic juice samples were collected at timed intervals and to secretin (12) . The reduced response to these secretagogues during the period of stimulation and for 2.5-3.5 hr after the is accompanied by changes in amylase and protein excretion and stimulation had ceased. All samples were collected under oil in by a reduction in total bicarbonate output (12) . The relationship preweighed microsample tubes and were kept in ice. The volume between bicarbonate or chloride concentrations and the flow rate of pancreatic juice in each sample was estimated gravimetrically were also abnormal in the pancreatic juice of the treated animals. by reweighing the collection tubes. At the end of the entire Physiologically, exocrine pancreatic secretion is thought to oc-collection period, the animal was killed by air insumation into the cur by two separate and independently regulated mechanisms thoracic cavity. The pancreas was carefully removed and weighed
to the nearest mg in a top loading balance. Bicarbonate concentrations were measured in 10 p1 aliquots in a Natelson microgasometer; chloride concentrations were determined in a Buchler chloride titrator and amylase concentrations by a colorimetric method that compares the difference in absorbance of a starchiodine complex in the sample with that of a blank (Harleco Co., Gibbstown, NJ). An amylase unit is defined as the amount of enzyme that will hydrolyze 10 mg of starch in 30 min.
The secretagogues used in this study were: 1) Pilocarpine nitrate. This agent was injected at a rate of 0.1 mg/min until a total dose of 0.2 mg/100 body weight was obtained. The injections were completed, therefore, in 3-6 min. 2) Dopamine hydrochloride, a neurohumoral agent that has been shown to cause the secretion of a secretin-like pancreatic juice in dogs (5) . A solution of 25 mg/ ml was prepared and infused at the rate of 18 pl/min. 3) Caemlein. A solution of this peptide was made in saline bicarbonate and was infused at the rate of 3.1 pmole/min. 4) Secretin. A solution of purified secretin was made in saline bicarbonate and was infused until a dose of 6 u/100 g body weight was achieved. In experiments where the two latter drugs were used in combination, the secretin was dissolved first and then caerulein was added to the desired of a smaller volume of juice and the maximum flow rates attained under these conditions of stimulation were the lowest in the entire series of experiments. Pilocarpine was more effective than dopamine in eliciting secretion and the maximum flow rate attained with the former was also higher.
The secretory response from the pancreas of reserpine-treated rats was characterized by the following 1) significantly lower volumes of pancreatic juice were secreted in all cases; and 2) the maximum flow rates attained were also significantly smaller than those attained by normal rats. In fact, the response to caerulein in fasted, reserpine-treated animals was extremely poor (Table 1) . Table I also shows the duration of the secretory response in both types of animals. In general, the response to dopamine, pilocarpine, caemlein, and to the caemlein-secretin combination lasted for approximately 3 hr. The response from reserpine-treated rats was also long lasting, except in the case of caemlein alone which caused a significantly shorter secretory response in these animals when compared to that of control rats.
SECRETION OF AMYLASE. BICARBONATE, A N D CHLORIDE
In order to further characterize the secretory response, the total output of amylase, bicarbonate, and chloride were calculated in all the expriments by adding the amount present in all the samples of pancreatic juice collected under each specific mode of stimulation. Table 2 shows the results for both control and treated animals. In control animals, amylase output was highest after stimulation with pilocarpine and smallest after stimulation with dopamine. Caemlein and the combination caemlein-secretin caused the secretion of intermediate amounts of amylase. Amylase output was significantly smaller (P < 0.01) in the juice of reserpine-treated rats, except when the caemlein-secretin combination was used. In this case, amylase output was greater in the juice of the treated animals.
The output of bicarbonate from the pancreas of control rats in experiments where dopamine was used as the stimulant was concentration. Pilocarpine, dopamine, and caerulein were all purchased from Sigma Chemical Co., St. Louis, MO. Purified secretin was purchased from the Gastrointestinal Hormone Laboratory of the Karolinska Institut, Stockholm, Sweden. Statistical analysis of the result was done by calculating mean values and SD of the mean and by using Student's t test. Table I shows the total volume of pancreatic juice secreted and the maximum flow rate attained with each of the various secretagogues used in these experiments. In control animals, the largest volume and highest flow rates were attained after stimulation with both caemlein and secretin. Caemlein alone caused the secretion substantial and similar to that caused by purified secretin (12) . Bicarbonate output was also significant in the juice of normal rats after stimulation with pilocarpine, but was much smaller when caerulein was used as the stimulant. A very large output of bicarbonate, significantly higher (P < 0.01) than those observed in the other experiments, was obtained in the juice of control rats when caerulein and secretin were given simultaneously. Bicarbonate output was significantly smaller (P < 0.005) in the pancreatic juice of reserpine-treated rats in all cases. Total chloride output was highest in the pancreatic juice of control rats after stimulation with the caerulein-secretin combination. It was also significant after pilocarpine stimu!ation. Both dopamine and caerulein caused the secretion of smaller amounts acinar cell function as a result of mutual cooperation between caerulein and secretin, because bicarbonate output was still significantly reduced under these conditions of stimulation ( Table  2) .
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RESULTS
I
SECRETORY RESPONSE
I
A reduction in the electrolyte fraction of pancreatic juice, alone or in combination with an overproduction of the organic fraction, was proposed as a possible explanation of the abnormal pancreatic secretory response in patients with CF (4). The results of these experiments suggest that similar changes are present in the pancreas of the reserpine-treated rat. The pancreatic disturbance in the animal model can be used, therefore, as a test system for further studies aimed at understanding the pathogenesis of the pancreatic secretory disturbance in CF. ofchloride. As in the case of bicarbonate, chloride output was -significantly reduced in the pancreatic juice of reserpine-treated CONCLUSIONS rats regardless of the type of stimulant used.
Rats treated in a chronic fashion with reserpine secrete a smaller
DISCUSSION
The results of this study demonstrate that the secretory capacity of the exocrine pancreas is significantly reduced in rats treated in a chronic fashion with reserpine. This alteration is manifested by the secretion of smaller volumes of pancreatic juice at reduced rates of flow and by reductions in the output of amylase, bicarbonate, and chloride after stimulation with pilocarpine, dopamine, and caerulein.
Because the drug-induced alteration involves the secretion of amylase and of fluid and bicarbonate, it can be asumed that it affects the two major secretory portions of the pancreas namely, the acinar and centroacinar (duct) cells, which are thought to be involved, respectively, in the secretion of the macromolecular and electrolyte (aqueous) fractions of pancreatic juice (3, 7, 8, 1 I) . A similar conclusion was reached in a previous study (12) . demonstrated a reduced response to both CCK and secretin. The present results indicate that the reduction in pancreatic secretory capacity after reserpine administration is a generalized effect involving not only the response to the regulatory hormones, but also to neurohumoral agents and to stimulatory peptides. Except in the case of caerulein, the reduced secretory response from the pancreas of reserpine-treated rats does not appear to be related to a shorter time course (Table 1) . It can be concluded, therefore, that the drug treatment affects the mechanism of secretion itself and that it impairs the response of both acinar and centroacinar cells to physiologic stimuli. The mechanism through which the drug treatment alters these responses can not be ascertained from the present results. The stimulus-secretion coupling mechanism in the exocrine pancreas is a complex process (1 1) involving not only an interaction between the neural and hormonal controls of acinar cells (6, 11) and possible interactions between the hormonal regulation of acinar and duct cells (3), but also a complex sequence of cellular events leading to secretion (I I). The toxic effect of reserpine administration could involve, therefore, alterations in secretagogue metabolism, in their interaction with cell receptors or in the intracellular metabolic pathways underlying secretion.
The observation that both amylase and fluid secretion increased in reserpine-treated animals when caerulein and secretin were administered simultaneously suggests that the reduced enzyme release can be overcome, at least partially, by improved fluid secretion. This finding does not clearly indicate, however, if this is merely a washout phenomenon secondary to an enhanced fluid secretion from centroacinar cells by secretin, or whether it results from an improved acinar cell function due to cooperative effects of the two secretagogues on these cells, as previously shown for cholecystokinin (CCK) and secretin (3) . Secretin has been shown to cause ultrastructural changes in acinar cells (1) and it has been proposed that acinar and duct cells not only have their own specific receptors but also those of the other cell type (3, 11) . The results of these experiments favor the possibility of an improved volume of pancreatic juice and smaller amounts of amylase and bicarbonate than untreated control animals, whether secretion is elicited by neurohumoral agents (pilocarpine, dopamine) or by a stimulatory peptide (caerulein) which mimics the action of CCK. Because these secretory responses are also reduced in the reserpine-treated rat after stimulation with secretin and with CCK, it was concluded that the drug treatment impairs the response of both acinar and ductal segments of the glandular epithelium to their physiologic regulators and that this effect causes an alteration in pancreatic function which resembles that which has been described in patients with CF. As such, the exocrine pancreatic abnormality induced by reserpine can be used as a model system for the study of pathogenic mechanisms in this disease.
